8:45am ET
Health and Healthcare
Big Pharma Scares Off Short Sellers
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Companies
/Healthcare
Lilly(Eli) & Company
$1,160.00
▲ $3.27 (+0.28%) today
Markets closed · 10:59pm ET
LLY Coverage
Page 22
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz, Procter & Gamble, Snap and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Best Buy, Eli Lilly, Hilton, Hyatt, Kraft Heinz, Procter & Gamble and Snap.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Chipotle, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre, US Steel and More
The top analyst upgrades, downgrades and initiations seen on Thursday included Apple, Chipotle Mexican Grill, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre and U.S. Steel.
9:40am ET
Health and Healthcare
Unbelievable Swings in Big Pharma Short Interest
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
8:50am ET
Health and Healthcare
Major Pharma Sees a Few Wild Swings in Short Interest
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
7:01am ET
Investing
Sell-Off or Not, 7 Blue Chips and Industry Leaders Analysts Want You to Buy Now
The week of March 22, 2019, ended on a very sour note with the markets selling off sharply. That said, there are always some stocks that manage to rise in hard times.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra Energy, Peabody Energy, Teva Pharmaceutical and Yum Brands.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AEP, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla, Vonage and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included American Electric Power, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla and Vonage.
8:35am ET
Health and Healthcare
Big Pharma Short Interest Backs Off, With One Huge Exception
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
7:00am ET
Investing
The 6 Most Shorted NYSE Stocks
Judging by the most shorted stocks traded on the New York Stock Exchange between the February 15 and February 28 settlement dates, those sellers were cautious overall, as moves were mixed and…
8:30am ET
Health and Healthcare
Major Pharma Sees Tremendous Rise in Short Interest
The February 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:35am ET
Health and Healthcare
Major Pharma Scares Off Short Sellers
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
10:15am ET
Investing
Alphabet, Disney, GM, Twitter and More Major Earnings Coming This Week
24/7 Wall St. has reviewed Disney, General Motors, Twitter and some of the other key stocks reporting earnings this coming week.
10:10am ET
Health and Healthcare
Short Interest Spikes in a Couple Major Pharma Stocks
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
9:50am ET
Health and Healthcare
Major Pharma Sees Fading Short Interest
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.